id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0147-0038,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Information Collection Request (ICR),2019-11-07T05:00:00Z,2019,11,2019-11-07T05:00:00Z,,2019-11-07T15:02:40Z,2019-24263,0,0,09000064841282e3
FDA-2011-D-0147-0037,FDA,FDA-2011-D-0147,Guidance for Industry and FDA Staff:  Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products,Other,Guidance,2019-06-05T04:00:00Z,2019,6,2019-06-05T04:00:00Z,,2024-11-12T23:02:14Z,,1,0,0900006483cec52f
FDA-2011-D-0147-0036,FDA,FDA-2011-D-0147,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products,Notice,30 Day Proposed Information Collection,2019-06-05T04:00:00Z,2019,6,2019-06-05T04:00:00Z,2019-07-06T03:59:59Z,2019-06-05T13:05:11Z,2019-11657,0,0,0900006483cebdee